BDBM238288 US10052306, 280::rac-(3aR,5R,6aS)-5- benzyl-2-[2-hydroxy-2- (4- hydroxyphenyl)propyl]- octahydrocyclopenta[c] pyrrol-5-ol

SMILES CC(O)(CN1CC2CC(O)(Cc3ccccc3)CC2C1)c1ccc(O)cc1

InChI Key InChIKey=OBOPZXBYNVDXIW-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 238288   

TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Cadent Therapeutics

US Patent
LigandPNGBDBM238288(US10052306, 280 | rac-(3aR,5R,6aS)-5- benzyl-2-[2-...)
Affinity DataIC50:  43nMAssay Description:To each well of the plate, 10 μL test compound, control (MK801) or HHnoCa buffer was added to a final concentration of 10 μM with a final c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent